Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

COVID-19 vaccines are about as effective as a single technological solution to a major threat can be — and our struggles to adopt and distribute the shots demonstrate their limits.

Why it matters: The pandemic is just one of many global challenges we'll face in the years ahead, but technofixes alone can't save us without a supportive social and political structure.

The big picture: Amid rising concern about the Delta variant's rapid spread and greatly increased infectiousness, it's worth remembering just how far we've come since the start of 2021.

  • In early January, the U.S. was averaging around 250,000 new COVID-19 cases every day, and more than 3,000 people a day were dying.
  • Our only ability to slow the spread involved socially and economically cumbersome strategies like shutdowns, social distancing and ubiquitous masking — little different from how we would have fought a pandemic a century ago.

Fast forward to August. Even with the Delta surge, cases and especially deaths and hospitalizations are vastly down from the winter peak — and it's almost entirely thanks to the effectiveness of the vaccines.

  • If you want to see how difficult it is to crush COVID-19 without widespread vaccination, look at Australia — vaccinated at less than 16% and back in lockdown — though you'd likely need to watch from a distance, as its borders remain effectively shut even to its expats.

Be smart: A vaccine as effective as the COVID-19 shots represents the ultimate example of a technofix — a fire-and-forget solution that solves a complex problem without the need for difficult social and political tradeoffs.

  • Or at least it might, if authorities could convince all eligible Americans to actually take the shots, and if they could organize an equitable distribution that would get vaccines to the billions of people still waiting.
  • Governors and legislators in some red states have banned vaccine mandates, taking off the table one of the best tools to improve uptake.
  • The result of those social and political failures is unnecessary illness and death and a higher chance SARS-CoV-2 will mutate into more dangerous variants. Plus, poorer countries have an estimated 270 million people — up from 150 million before the pandemic — who are facing life-threatening food shortages.

Yes, but: Technologies are never deployed in a vacuum.

  • "We have this idea of technology as a silver bullet, rather than something more prosaic, one tool among many," Alexa Hagerty, former research associate at Cambridge University's Centre for the Study of Existential Risk, said on a recent panel. "But technology doesn't just travel solo."
  • Even the best vaccines in the world — and the mRNA COVID-19 vaccines can plausibly lay claim to that title — will be hobbled if political divisions and social distrust mean millions of people refuse to take them, and if geopolitics prevent them from even reaching those who need them most.

Between the lines: The troubled rollout of the COVID-19 vaccines should give us pause before we count on similar technofixes to bail us out of future threats — especially since few of them will be as amenable to a single technological solution as a pandemic.

  • Climate change is the ultimate example of a global challenge that will likely require extreme technological fixes — think technology to capture carbon from the air or even solar geoengineering — but will still depend on hard political and social choices.
  • Disinformation online can be partially addressed through better AI screening, but the deeper challenges lay in defusing a social environment that has led so many people to believe things that are so false — and no technology invented yet can do that.

The bottom line: Even the most effective technofixes are dependent on the social and political environment in which they're deployed.

Go deeper

Oct 14, 2021 - Health

FDA panel unanimously endorses Moderna boosters for certain populations

A pharmacist prepares to give a COVID-19 booster vaccination. Photo: Karwai Tang/Getty Images

Members of the Food and Drug Administration's vaccine expert panel on Thursday endorsed boosters for Moderna recipients who are at high risk of severe COVID-19, occupational exposure to COVID-19 or are 65 years and older.

Why it matters: The unanimous decision mirrors the FDA conditions for those who qualify for a Pfizer booster.

Virginia energy giant quietly boosts McAuliffe

Former Virginia Gov. Terry McAuliffe speaks during a campaign rally on Oct. 15 in Henrico, Virginia. Photo: Win McNamee/Getty Images

Virginia Democrat Terry McAuliffe has sworn off money from the Richmond company Dominion Energy. But the utility has found more subtle ways to back McAuliffe's gubernatorial bid, records show.

Driving the news: Dominion's political action committee has donated $200,000 to a murky political group called Accountability Virginia PAC, which has been running ads attacking Republican candidate Glenn Youngkin.

2 hours ago - Technology

Race and technology in America

Illustration: Annelise Capossela/Axios

The technology industry is famously determined to change the world — but its efforts to diversify its workforce and remove bias from its products haven't changed nearly enough.